Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Caffeine Decreases the Frequency of Opioid Demand in AIS Patients After Spinal Fusion

NCT04950660 is registered in ClinicalTrials.gov with Children's Mercy Hospital Kansas City as lead sponsor.

NCT NCT04950660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04950660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Caffeine Decreases the Frequency of Opioid Demand in AIS Patients After Spinal Fusion
Lead sponsor
Children's Mercy Hospital Kansas City
Phase
Phase 4
Overall status
Completed
Start date
December 11, 2019
Completion date
August 1, 2024
Enrollment
61 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adolescent idiopathic scoliosis